- Home
- ERII vs MGTX Comparison
ERII vs MGTX Comparison
Compare ERII & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ERII
- MGTX
- Stock Information
- Founded
- ERII 1992
- MGTX 2015
- Country
- ERII United States
- MGTX United States
- Employees
- ERII N/A
- MGTX N/A
- Industry
- ERII Industrial Machinery/Components
- MGTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ERII Technology
- MGTX Health Care
- Exchange
- ERII Nasdaq
- MGTX Nasdaq
- Market Cap
- ERII 661.1M
- MGTX 622.0M
- IPO Year
- ERII 2008
- MGTX N/A
- Fundamental
- Price
- ERII $13.88
- MGTX $8.37
- Analyst Decision
- ERII Buy
- MGTX Strong Buy
- Analyst Count
- ERII 3
- MGTX 2
- Target Price
- ERII $18.17
- MGTX $24.00
- AVG Volume (30 Days)
- ERII 409.4K
- MGTX 563.1K
- Earning Date
- ERII 08-06-2025
- MGTX 08-11-2025
- Dividend Yield
- ERII N/A
- MGTX N/A
- EPS Growth
- ERII 9.93
- MGTX N/A
- EPS
- ERII 0.37
- MGTX N/A
- Revenue
- ERII $140,923,000.00
- MGTX $34,508,000.00
- Revenue This Year
- ERII $4.82
- MGTX $228.65
- Revenue Next Year
- ERII $12.97
- MGTX $145.06
- P/E Ratio
- ERII $37.44
- MGTX N/A
- Revenue Growth
- ERII 10.93
- MGTX 203.23
- 52 Week Low
- ERII $10.86
- MGTX $3.85
- 52 Week High
- ERII $20.27
- MGTX $8.98
- Technical
- Relative Strength Index (RSI)
- ERII 65.66
- MGTX 62.96
- Support Level
- ERII $12.82
- MGTX $8.32
- Resistance Level
- ERII $13.87
- MGTX $8.95
- Average True Range (ATR)
- ERII 0.31
- MGTX 0.40
- MACD
- ERII 0.08
- MGTX -0.07
- Stochastic Oscillator
- ERII 86.89
- MGTX 52.16
About ERII Energy Recovery Inc.
Energy Recovery Inc is an engineering-driven technology company. It is engaged in engineering, designing, manufacturing and supplying solutions that make industrial processes more efficient and sustainable. The company operates in three segments, Water, Emerging Technologies and Corporate. It offers energy recovery devices (ERDs) and pumps as well as related products and services to the global reverse osmosis desalination market. The company derives a majority of the revenue from the Water segment. Geographically, the company operates in the U.S. and other international countries.
About MGTX MeiraGTx Holdings plc
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.